Reaction Details |
| Report a problem with these data |
Target | Cannabinoid receptor 1 |
---|
Ligand | BDBM50420902 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_840018 (CHEMBL2090508) |
---|
Ki | >10000±n/a nM |
---|
Citation | Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida, F; Luongo, L; Varani, K; Borea, PA; Maione, S; Di Marzo, V; Corelli, F Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. J Med Chem55:5391-402 (2012) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cannabinoid receptor 1 |
---|
Name: | Cannabinoid receptor 1 |
Synonyms: | CANN6 | CANNABINOID CB1 | CB-R | CB1 | CNR | CNR1 | CNR1_HUMAN | Cannabinoid CB1 receptor | Cannabinoid receptor | Cannabinoid receptor 1 (CB1) | Cannabinoid receptor 1 (brain) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 52868.96 |
Organism: | Homo sapiens (Human) |
Description: | P21554 |
Residue: | 472 |
Sequence: | MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQE
KMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIA
VLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVF
HRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLM
WTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWK
AHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLL
AIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQ
PLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
|
|
|
BDBM50420902 |
---|
n/a |
---|
Name | BDBM50420902 |
Synonyms: | CHEMBL2087113 |
Type | Small organic molecule |
Emp. Form. | C26H28N2O |
Mol. Mass. | 384.5133 |
SMILES | O=C(Cc1c[nH]c2ccc(cc12)-c1ccccc1)NC12CC3CC(CC(C3)C1)C2 |TLB:18:19:22:26.25.24,THB:20:21:24:28.19.27,20:19:22.21.26:24,27:19:22:26.25.24,27:25:22:28.20.19| |
Structure |
|